Brief: Stevanato Group S.p.A., Bexson Biomedical Expand Collaboration
April 29 (Reuters) - Stevanato Group SpA STVN.N :
* STEVANATO GROUP S.P.A. AND BEXSON BIOMEDICAL, INC. EXPAND
COLLABORATION TO TREAT A RANGE OF MENTAL HEALTH CONDITIONS WITH
AN ON-BODY DEVICE
* STEVANATO - AGREEMENT TO GRANT BEXSON ACCESS TO USE OF
CO'S
WEARABLE DELIVERY SYSTEM TO DEVELOP NEW THERAPEUTICS TO TREAT
RANGE OF MENTAL HEALTH CONDITIONS
Source text for Eikon: ID:nBw9lKhv5a
Further company coverage: STVN.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stevanato SpA
See all newsStevanato Group SpA reports results for the quarter ended June 30 - Earnings Summary
Corrected: BRIEF-Stevanato Q2 Net Income EUR 23 Million
SCHOTT Pharma jumps as DB ups to 'buy' on growth prospects
Italy's Stevanato Q1 revenue rises more than expected, helped by GLP-1 demand
Italy's Stevanato Q4 revenue beats on BDS unit strength